  |
|
|
 |
On 1/25/2010 Anne is a speaker on a Life Science Angel Investors Panel: Trends for 2010Anne DeGheest will be a speaker at FountainBlue: Life Science Entrepreneurs Forum on January 25, 2010. Topics will include how early stage companies can position themselves for successful partnerships and fundings, strategically plan your business based on evolving market needs, tightly manage cash flow, and build strategic alliances with larger organizations, angels, research organizations, and other key stakeholders http://www.fountainblue.biz/lifescience.html
Below is a summary of some of the panel comments and advices to entrepreneurs looking for angel capital: Our panelists started by remarking on both the fact that there were 40% fewer dollars AND 30% fewer deals than in 2009, the lowest level of activity since 1997, however, they remarked that angel investing is still very active with smaller amounts for more deals. But as 10% of the deals have paid 75% of the total returns, many investors, particularly early stage investors who are more likely to get diluted in future rounds, and who might have incurred huge losses, are much more cautious. VCs are actually even more cautious, waiting for angels to vet and fund early stage companies. As one investor put it, ‘there is no money on the sidelines' - investors are already "all-in". There is also unlikely to be additional money as we are all "exit challenged", with the disappearance of the IPOs. Anne DeGheest | 22 January 2010 PMWC 2010: Personalized Medicine 2010 conference
The conference was examining the emerging field of personalized medicine that is already providing benefits for the health care industry, while simultaneously looking at new business opportunities within the Life sciences marketplace.
Anne DeGheest | 22 January 2010 MedStars is Attending JP Morgan and OneMedPlace Conferences the week of January 11, 2010It’s a big week for healthcare and healthcare startups the week of January 11 to 14 in the San Francisco Bay Area. As it has for many years, the JP Morgan Healthcare conference is in town, and it attracts nearly all of the large investment bank, venture and private capital going into healthcare company investments, not to mention nearly all the major pharmaceutical, biotechnology, medical device, and healthcare IT companies. Anne DeGheest | 11 January 2010 |
 |
||||
|
 |
||||||
On January 19 and 20, 2010, we attended the Personalized Medicine conference sponsored by Stanford, UCSF and Silicom Ventures. 
